Related Experiment Video
Updated: May 20, 2025
06:08
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
1.6K
Interleukin 8 Molecular Interplay in Allergic Rhinitis and Chronic Rhinosinusitis with Nasal Polyps: A Scoping Review
Romica Cergan1, Ovidiu Berghi2, Mihai Dumitru3
1Anatomy Department, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Life (Basel, Switzerland)
|March 27, 2025
Summary
Interleukin-8 (IL-8) is a key immune mediator linking allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyps (CRSwNP). Further research is needed to explore IL-8 as a potential target for biologic treatments.
Area of Science:
- Immunology
- Otorhinolaryngology
Background:
- Allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyps (CRSwNP) are inflammatory upper airway diseases.
- Both conditions share overlapping molecular mechanisms, particularly involving immune mediators.
- Interleukin-8 (IL-8) has emerged as a significant interconnecting factor in their pathophysiology.
Purpose of the Study:
- To review and synthesize the existing literature on the molecular interplay between AR, CRSwNP, and IL-8.
- To identify the role of IL-8 in the disease mechanisms of AR and CRSwNP.
- To highlight gaps in current research and suggest future directions.
Main Methods:
- A scoping review methodology was employed.
- A comprehensive search of the PubMed database was conducted.
- 34 articles were included in the final analysis.
Main Results:
- IL-8 acts as a crucial immune mediator in the pathogenesis of both AR and CRS.
- IL-8 facilitates neutrophil recruitment to the nasal mucosa, contributing to inflammation.
- Clinical and fundamental studies confirm IL-8's involvement in AR and CRSwNP disease mechanisms.
Conclusions:
- IL-8 plays a significant role in the molecular interplay of AR and CRSwNP.
- A large-scale randomized controlled trial comparing normal controls, AR, and CRSwNP patients regarding IL-8 impact is warranted.
- Targeting IL-8 may offer a future therapeutic strategy for biologic treatments in these conditions.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
320
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
320
01:24T Cell Types and Functions
724
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
724
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
293
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
293
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:28Inflammatory Response
1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K